This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07246/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07246/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07246/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07246/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07246/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07246
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n11:DB07246 n14:DB07246
dcterms:title
(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE
adms:identifier
n7:99443717 n8:7MR n9:16129579 n12:17286395 n13:DB07246
n4:IUPAC-Name
n5:271B5862-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B5868-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B5867-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B5864-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B5865-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B5866-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B5860-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B585E-363D-11E5-9242-09173F13E4C5 n5:271B5861-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B585F-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B586E-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B586F-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B5869-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B586A-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B586C-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B586B-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B586D-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B5874-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B5876-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B5877-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B5873-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B5872-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B5875-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B5863-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5870-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B5871-363D-11E5-9242-09173F13E4C5